Aligos Therapeutics (ALGS)

• Market cap: $43.3M
• 1 day: -6.27%
• 5 days: 2.63%
• 1 month: -18.16%
• 3 months: -26.62%
• 6 months: -37.95%
• Year to date: -23%
• 1 year: -58.05%
• 5 years: -99.04%
• 10 years: -98.11%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70